Cann GroupASX:CAN -25.00% Days Payable is 666.52 as of Dec. 2025, which is 78% below its 10-year median of 3,085.68. The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Cann Group ranks worse than 108342.25% on this metric.
Cann Group's average Accounts Payable for the
six
months ended in Dec. 2025 was A$5.37 Mil. Cann Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was A$1.47 Mil.
Hence, Cann Group's Days Payable for the
six
months ended in Dec. 2025 was 666.52.
The historical rank and industry rank for Cann Group's Days Payable or its related term are showing as below:
During the past 9 years, Cann Group's highest Days Payable was 54514.27. The lowest was 2241.30. And the median was 3085.68.
ASX:CAN's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.98 * Ranked among companies with meaningful Days Payable only.
Cann Group's Days Payable
increased
from Dec. 2024 (292.73) to Dec. 2025 (666.52).
It may suggest that Cann Groupdelayed paying its suppliers.
Cann Group Days Payable Related Terms
Cann Group Days Payable Historical Data
* Premium members only.
The historical data trend for Cann Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cann Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cann Group Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cann Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Cann Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cann Group's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cann Group (ASX:CAN) has a Days Payable of 666.52 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cann Group and its competitors. This is 78% below median its historical median of 3,085.68. Over the past decade, Cann Group's Days Payable has ranged from 2,241.30 to 54,514.27. According to the industry distribution chart, Cann Group ranks #999999 out of 923 companies in the Drug Manufacturers industry.
Is Cann Group's Days Payable too high?
Cann Group's current Days Payable of 666.52 is 78% below median its 10-year median of 3,085.68. Over the past 10 years, this metric has ranged from a low of 2,241.30 to a high of 54,514.27. The Drug Manufacturers industry median Days Payable is 90.98. Cann Group's value of 666.52 is 632.6% above this industry median. Based on the distribution chart, Cann Group ranks #999999 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cann Group's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Cann Group ranks #999999 out of 923 companies for Days Payable. This places Cann Group in the lower half of its industry. The industry median Days Payable is 90.98. Cann Group's value of 666.52 is 632.6% above this benchmark. Historically, Cann Group's own Days Payable has ranged from 2,241.30 to 54,514.27 over the past decade. While the company's 10-year median is 3,085.68 vs. the industry median of 90.98, Cann Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cann Group's current Days Payable of 666.52 is 632.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cann Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cann Group's current Days Payable is 666.52, which is 78% below median its own 10-year median of 3,085.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann Group stock overvalued right now?
Based on GuruFocus' analysis, Cann Group (ASX:CAN) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 85% below its estimated fair value. The current Days Payable is 666.52, which is 78% below median its 10-year median of 3,085.68 and 632.6% above the Drug Manufacturers industry median of 90.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cann Group (ASX:CAN), the current Days Payable is 666.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CAN has been successfully added to your 